| Issue Type | Login |
|---|---|
| Country | Switzerland |
| Industry | Login |
| Region | Login |
| Maturity Date | 2029-11-13 |
| Par Value | 5000000 |
| Callable | Login |
| Next Call Date | Login |
| Call Type | Login |
| Call Price (%) | Login |
| Series | Login |
| Class | Login |
| Maturity Structure | Login |
| Amount Outstanding (mil) | 550.00 |
| Coupon | 0.625 |
|---|---|
| Coupon Type | Login |
| Coupon Frequency | Login |
| First Coupon Date | Login |
| Last Coupon Date | Login |
| Sinking Fund | Login |
|---|---|
| Security | Login |
| Subordination | Login |
| Debt Type | Login |
| Issue Date | Login |
|---|---|
| Dated Date | Login |
| Issue Size (mil) | 550 |
| Min. Piece | Login |
| Min. Increment | Login |
This Novartis AG corporate medium term notes has a 0.63% fixed rate coupon paid on a Login basis. It was issued on MAR 12, 2000 with an issue size of 550.00 million CHF and matures on November 13, 2029 with a last coupon date of FEB 28, 2020. |
Novartis AG, founded in 1996 and headquartered in Basel, Switzerland, is a leading global healthcare company focused on providing innovative medicines and treatments to improve patients' lives. The company specializes in pharmaceuticals, eye care, and generics, with well-known products including the cancer treatment Gleevec and the heart failure drug Entresto.